 |
PDBsum entry 6ycc
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Structure the ananain protease from ananas comosus covalently bound to the e64 inhibitor
|
|
Structure:
|
 |
Ananain. Chain: a, b. Ec: 3.4.22.31
|
|
Source:
|
 |
Ananas comosus. Pineapple. Organism_taxid: 4615
|
|
Resolution:
|
 |
|
1.30Å
|
R-factor:
|
0.145
|
R-free:
|
0.169
|
|
|
Authors:
|
 |
M.Azarkan,P.Charlier,R.Herman,F.Delbrassine,E.Sauvage,N.M Rabet, R.Calvo Esposito,F.Kerff
|
|
Key ref:
|
 |
M.Azarkan
et al.
(2020).
Structures of the free and inhibitors-bound forms of bromelain and ananain from Ananas comosus stem and in vitro study of their cytotoxicity.
Sci Rep,
10,
19570.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
18-Mar-20
|
Release date:
|
25-Nov-20
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P80884
(ANAN_ANACO) -
Ananain from Ananas comosus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
345 a.a.
215 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.22.31
- ananain.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of proteins with broad specificity for peptide bonds. Best reported small molecule substrate Bz-Phe-Val-Arg-|-NHMec, but broader specificity than fruit bromelain.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Sci Rep
10:19570
(2020)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structures of the free and inhibitors-bound forms of bromelain and ananain from Ananas comosus stem and in vitro study of their cytotoxicity.
|
|
M.Azarkan,
E.Maquoi,
F.Delbrassine,
R.Herman,
N.M'Rabet,
R.Calvo Esposito,
P.Charlier,
F.Kerff.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Ananas comosus stem extract is a complex mixture containing various cysteine
proteases of the C1A subfamily, such as bromelain and ananain. This
mixture used for centuries in Chinese medicine, has several potential
therapeutic applications as anti-cancer, anti-inflammatory and ecchymosis
degradation agent. In the present work we determined the structures of bromelain
and ananain, both in their free forms and in complex with the inhibitors E64 and
TLCK. These structures combined with protease-substrate complexes modeling
clearly identified the Glu68 as responsible for the high discrimination of
bromelain in favor of substrates with positively charged residues at P2, and
unveil the reasons for its weak inhibition by cystatins and E64. Our results
with purified and fully active bromelain, ananain and papain show a strong
reduction of cell proliferation with MDA-MB231 and A2058 cancer cell lines at a
concentration of about 1 μM, control experiments clearly emphasizing the need
for proteolytic activity. In contrast, while bromelain and ananain had a strong
effect on the proliferation of the OCI-LY19 and HL-60 non-adherent cell lines,
papain, the archetypal member of the C1A subfamily, had none. This indicates
that, in this case, sequence/structure identity beyond the active site of
bromelain and ananain is more important than substrate specificity.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |